Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Recruiting now

Conditions studied: Parkinson Disease, Dystonia, Essential Tremor, Movement Disorders

In brief

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.

Key facts

Study ID

NCT06553625

Run by

Boston Scientific Corporation

People needed

200

Starts

2024-01-29

Expected to finish

2035-12-01

Last updated by the study team

2026-08-04

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain or for CNS applications per local Directions for Use (DFU)
• Signed a valid, IRB/EC/REB-approved informed consent form

You may not qualify if…

• Meets any contraindications per locally applicable Directions for Use (DFU)
• Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments

Where it is running

• Uniklinik Köln — Cologne, Germany (enrolling)
• Universitaetsklinikum Dusseldorf — Düsseldorf, Germany (enrolling)
• Universitaetsklinikum Wuerzburg — Würzburg, Germany (enrolling)
• St. Georges Hospital — London, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.